Soy, isoflavones, and breast cancer risk in Japan
- PMID: 12813174
- DOI: 10.1093/jnci/95.12.906
Soy, isoflavones, and breast cancer risk in Japan
Abstract
Background: Although isoflavones, such as those found in soy, have been shown to inhibit breast cancer in laboratory studies, associations between consumption of isoflavone-containing foods and breast cancer risk have been inconsistent in epidemiologic studies. We evaluated the relationship between isoflavone consumption and breast cancer risk among women in the Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Diseases (JPHC Study).
Methods: In January 1990, 21 852 Japanese female residents (aged 40-59 years) from four public health center areas completed a self-administered questionnaire, which included items about the frequency of soy consumption. Through December 1999 and 209 354 person-years of follow-up, 179 women were diagnosed with breast cancer. Cox proportional hazards regression was used to estimate the relative risks (RRs) and 95% confidence intervals (CIs) for breast cancer in relation to consumption of miso soup, soyfoods, and estimated isoflavones. All statistical tests were two-sided.
Results: Consumption of miso soup and isoflavones, but not of soyfoods, was inversely associated with the risk of breast cancer. The associations did not change substantially after adjustment for potential confounders, including reproductive history, family history, smoking, and other dietary factors. Compared with those in the lowest quartile of isoflavone intake, the adjusted RRs for breast cancer for women in the second, third, and highest quartiles were 0.76 (95% CI = 0.47 to 1.2), 0.90 (95% CI = 0.56 to 1.5), and 0.46 (95% CI = 0.25 to 0.84), respectively (P(trend) =.043). The inverse association was stronger in postmenopausal women (P(trend) =.006).
Conclusion: In a population-based, prospective cohort study in Japan, frequent miso soup and isoflavone consumption was associated with a reduced risk of breast cancer.
Comment in
-
Re: Soy, isoflavones, and breast cancer risk in Japan.J Natl Cancer Inst. 2003 Dec 17;95(24):1881-2; author reply 1881-2. doi: 10.1093/jnci/djg131. J Natl Cancer Inst. 2003. PMID: 14679159 No abstract available.
Similar articles
-
Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan public health center-based prospective study.Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2128-35. doi: 10.1158/1055-9965.EPI-08-0182. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18708407
-
Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I.Circulation. 2007 Nov 27;116(22):2553-62. doi: 10.1161/CIRCULATIONAHA.106.683755. Epub 2007 Nov 19. Circulation. 2007. PMID: 18025534
-
Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. doi: 10.1093/jnci/djk096. J Natl Cancer Inst. 2007. PMID: 17374837 Free PMC article.
-
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.Nutr J. 2008 Jun 3;7:17. doi: 10.1186/1475-2891-7-17. Nutr J. 2008. PMID: 18522734 Free PMC article. Review.
-
High soy isoflavone or soy-based food intake during infancy and in adulthood is associated with an increased risk of uterine fibroids in premenopausal women: a meta-analysis.Nutr Res. 2019 Nov;71:30-42. doi: 10.1016/j.nutres.2019.06.002. Epub 2019 Jun 8. Nutr Res. 2019. PMID: 31668644 Review.
Cited by
-
Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis.Sci Rep. 2016 May 12;6:25939. doi: 10.1038/srep25939. Sci Rep. 2016. PMID: 27170217 Free PMC article. Review.
-
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish.Cancer Sci. 2004 Apr;95(4):290-9. doi: 10.1111/j.1349-7006.2004.tb03205.x. Cancer Sci. 2004. PMID: 15072585 Free PMC article. Review.
-
Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.J Nutr Biochem. 2007 Jun;18(6):380-90. doi: 10.1016/j.jnutbio.2006.06.002. Epub 2006 Sep 8. J Nutr Biochem. 2007. PMID: 16963248 Free PMC article. Clinical Trial.
-
Lunasin: a novel cancer preventive seed Peptide.Perspect Medicin Chem. 2008 Mar 25;2:75-80. doi: 10.4137/pmc.s372. Perspect Medicin Chem. 2008. PMID: 19787099 Free PMC article.
-
Exploring the Mechanism of Flavonoids Through Systematic Bioinformatics Analysis.Front Pharmacol. 2018 Aug 15;9:918. doi: 10.3389/fphar.2018.00918. eCollection 2018. Front Pharmacol. 2018. PMID: 30158870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical